Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Jill K TerraKenneth A Bradley

Abstract

Pathogenesis of Bacillus anthracis is associated with the production of lethal toxin (LT), which activates the murine Nalp1b/Nlrp1b inflammasome and induces caspase-1-dependent pyroptotic death in macrophages and dendritic cells. In this study, we investigated the effect of allelic variation of Nlrp1b on the outcome of LT challenge and infection by B. anthracis spores. Nlrp1b allelic variation did not alter the kinetics or pathology of end-stage disease induced by purified LT, suggesting that, in contrast to previous reports, macrophage lysis does not contribute directly to LT-mediated pathology. However, animals expressing a LT-sensitive allele of Nlrp1b showed an early inflammatory response to LT and increased resistance to infection by B. anthracis. Data presented here support a model whereby LT-mediated activation of Nlrp1b and subsequent lysis of macrophages is not a mechanism used by B. anthracis to promote virulence, but rather a protective host-mediated innate immune response.

References

Mar 1, 1986·Infection and Immunity·S L WelkosP H Gibbs
Jan 1, 1988·Microbial Pathogenesis·S L Welkos, A M Friedlander
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P C HannaR J Collier
Mar 29, 2000·Protein Expression and Purification·S Park, S H Leppla
Mar 14, 2002·Biochemical and Biophysical Research Communications·John KalnsJohnathan Kiel
Aug 30, 2003·Science·Feng ShaoRoger W Innes
Mar 11, 2004·The Journal of Biological Chemistry·Ruth Cordoba-RodriguezDavid M Frucht
Sep 24, 2005·Infection and Immunity·Nathan C CulleySteven M LeVine
Jan 24, 2006·Nature Genetics·Eric D Boyden, William F Dietrich
Sep 22, 2006·Expert Reviews in Molecular Medicine·Alison Brewer, John Pizzey
Apr 19, 2007·The Pharmacogenomics Journal·S H NyeH J Jacob
May 22, 2008·European Journal of Immunology·Tae Jin KangAlan S Cross
May 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Li-Chung HsuMichael Karin
Sep 5, 2008·PloS One·Pradeep K GuptaStephen H Leppla
Jan 6, 2009·Immunological Reviews·Luigi FranchiGabriel Nuñez

❮ Previous
Next ❯

Citations

May 15, 2013·EMBO Molecular Medicine·Franz Bauernfeind, Veit Hornung
Aug 21, 2012·Nature·Jakob von MoltkeRussell E Vance
Mar 21, 2012·Nature Immunology·Luigi FranchiGabriel Núñez
Feb 8, 2011·The Journal of Biological Chemistry·Hal M Hoffman, Susannah D Brydges
Sep 22, 2010·Infection and Immunity·Robert E Bolcome, Joanne Chan
Dec 12, 2012·Infection and Immunity·Kuo-Chieh Liao, Jeremy Mogridge
Feb 20, 2010·American Journal of Respiratory and Critical Care Medicine·Bastian OpitzNorbert Suttorp
Mar 23, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrew W Artenstein, Steven M Opal
Jan 12, 2011·Annual Review of Immunology·Beckley K DavisJenny P-Y Ting
Dec 12, 2012·Annual Review of Immunology·Jakob von MoltkeRussell E Vance
Nov 30, 2011·TheScientificWorldJournal·Manoranjan SahooFabio Re
Sep 15, 2012·Annual Review of Cell and Developmental Biology·Mohamed Lamkanfi, Vishva M Dixit
Nov 13, 2013·Infection and Immunity·Sarah E EwaldJohn C Boothroyd
Aug 20, 2015·Toxins·Christopher K Cote, Susan L Welkos
Feb 13, 2016·Frontiers in Microbiology·Ana do ValeSandra Sousa
Dec 1, 2015·Frontiers in Immunology·Allison J GreaneyMahtab Moayeri
Oct 27, 2015·Frontiers in Microbiology·Pierre L Goossens, Jean-Nicolas Tournier
Jul 22, 2015·Annual Review of Microbiology·Mahtab MoayeriShihui Liu
Mar 16, 2016·Toxins·Sarah FriebeJérôme Bürgi
May 2, 2012·Virulence·Christopher R Lupfer, Thirumala-Devi Kanneganti
Feb 3, 2015·The Journal of Clinical Investigation·Tyler K UllandFayyaz S Sutterwala
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Eugene J GillespieKenneth A Bradley
Feb 14, 2017·Annual Review of Physiology·Judie A Howrylak, Kiichi Nakahira
May 17, 2013·Innate Immunity·Gabriel SollbergerHans-Dietmar Beer
Jul 27, 2010·Veterinary Pathology·N A Twenhafel
Nov 10, 2017·International Journal of Molecular Sciences·Nicole RansonRajaraman Eri
Jan 22, 2018·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Alaa Alhazmi
Dec 3, 2017·Journal of Cell Science·Ankit Malik, Thirumala-Devi Kanneganti
Jan 31, 2014·The Journal of Biological Chemistry·Johanna RiveraDavid L Goldman
Jul 29, 2010·Journal of Clinical Immunology·Vijay A K Rathinam, Katherine A Fitzgerald
Apr 23, 2013·Nature Chemical Biology·Erik C HettDeborah T Hung
Feb 26, 2011·Nature Reviews. Immunology·Mohamed Lamkanfi
Jul 19, 2011·Clinical and Experimental Immunology·P Menu, J E Vince
Sep 3, 2011·Immunological Reviews·Mohamed LamkanfiThirumala-Devi Kanneganti
Mar 20, 2012·Immunologic Research·Lia Paola ZambettiAlessandra Mortellaro
Jul 3, 2019·Cellular Microbiology·Nathaniel WinsorStephen E Girardin
Jul 6, 2014·Immunologic Research·Gwendolyn M ClayMary E Wilson
Sep 11, 2019·Cold Spring Harbor Perspectives in Biology·Carolyn A Lacey, Edward A Miao
Oct 2, 2019·Cold Spring Harbor Perspectives in Biology·Nathalia M de Vasconcelos, Mohamed Lamkanfi
Apr 27, 2012·PLoS Pathogens·Bradley C FrewJeremy Mogridge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.